KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
Want to see KALV full AI Analyst Report?
Comparison Results
KalVista Pharmaceuticals
$20.48
$1.37B
-47.34
135.98%
2 Buy
6 Hold
0 Sell
Hold
Arvinas Holding Company
$11.00
$607.79M
-2.94
55.19%
9 Buy
6 Hold
1 Sell
Moderate Buy
Compass Therapeutics
$6.00
$356.57M
-13.46
-1.00%
11 Buy
1 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$24.01
$1.36B
-5.37
50.73%
9 Buy
2 Hold
0 Sell
Strong Buy
Performance Comparison
KALV
KalVista Pharmaceuticals
26.76
15.10
129.50%
SVRA
Savara
5.27
2.16
69.45%
ARVN
Arvinas Holding Company
9.42
3.16
50.48%
GOSS
Gossamer Bio
0.33
-0.72
-68.57%
CMPX
Compass Therapeutics
1.98
-0.04
-1.98%
BCAX
Bicara Therapeutics Inc.
20.65
6.18
42.71%